Members |
targetComponentId |
surdose de ceftazidime d'intention indéterminée |
Ceftazidime overdose |
intoxication par la ceftazidime d'intention indéterminée |
Ceftazidime poisoning |
surdose de ceftibutène d'intention indéterminée |
Ceftibuten overdose |
intoxication par le ceftibutène d'intention indéterminée |
Ceftibuten poisoning |
Ceftizoxime overdose of undetermined intent |
Ceftizoxime overdose |
Ceftizoxime poisoning of undetermined intent |
Ceftizoxime poisoning |
Ceftriaxone 500mg injection (pdr for recon) |
Ceftriaxone (as ceftriaxone sodium) 500 mg powder for solution for injection vial |
surdose de ceftriaxone d'intention indéterminée |
Ceftriaxone overdose |
intoxication par la ceftriaxone d'intention indéterminée |
Ceftriaxone poisoning |
Ceftriaxone sodium 1g injection |
Ceftriaxone (as ceftriaxone sodium) 1 g powder for solution for injection vial |
Ceftriaxone sodium 1g powder for injection |
Ceftriaxone (as ceftriaxone sodium) 1 g powder for solution for injection vial |
Ceftriaxone sodium 1g/vial powder |
Ceftriaxone (as ceftriaxone sodium) 1 g powder for solution for injection vial |
Ceftriaxone sodium 250mg injection |
Ceftriaxone (as ceftriaxone sodium) 250 mg powder for solution for injection vial |
Ceftriaxone sodium 250mg powder for injection |
Ceftriaxone (as ceftriaxone sodium) 250 mg powder for solution for injection vial |
Ceftriaxone sodium 2g injection |
Product containing precisely ceftriaxone (as ceftriaxone sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Ceftriaxone sodium 2g powder for injection |
Product containing precisely ceftriaxone (as ceftriaxone sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Ceftriaxone sodium 2g/vial powder |
Product containing precisely ceftriaxone (as ceftriaxone sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Ceftriaxone sodium 500mg injection |
Ceftriaxone (as ceftriaxone sodium) 500 mg powder for solution for injection vial |
Cefuroxime axetil 125mg/5ml powder for suspension |
Cefuroxime (as cefuroxime axetil) 25 mg/mL oral suspension |
Cefuroxime axetil 250mg/5 mL powder for suspension |
Cefuroxime (as cefuroxime axetil) 50 mg/mL oral suspension |
Cefuroxime axetil 250mg/5mL powder |
Cefuroxime (as cefuroxime axetil) 50 mg/mL oral suspension |
surdose de céfuroxime d'intention indéterminée |
Cefuroxime overdose (disorder) |
intoxication par le céfuroxime d'intention indéterminée |
Cefuroxime poisoning |
Celery RAST test |
Celery specific IgE antibody measurement |
Celiac branch of vagus |
Structure of vagus nerve celiac branch (body structure) |
Cell chromosome exam. abnormal |
Cell chromosome examination abnormal (finding) |
Cell chromosome exam. normal |
Cell chromosome examination normal (finding) |
Cell chromosome examination |
Cell chromosome examination |
Cell chromosome examination request |
Cell chromosome examination request |
Cell count |
Cell count |
Cell count |
Cell count |
Cell count |
Cell count |
Cell count, body fluid |
Cell count, body fluid |
Cell count, cerebrospinal fluid |
Cell count, cerebrospinal fluid |
Cell count, cerebrospinal fluid |
Cell count, cerebrospinal fluid |
Cell count, cerebrospinal fluid |
Cell count, cerebrospinal fluid |
Cell count, peritoneal fluid |
Cell count, peritoneal fluid |
Cell count, peritoneal fluid |
Cell count, peritoneal fluid |
Cell count, peritoneal fluid |
Cell count, peritoneal fluid |
Cell count, pleural fluid |
Cell count, pleural fluid (procedure) |
Cell count, pleural fluid |
Cell count, pleural fluid (procedure) |
Cell count, pleural fluid |
Cell count, pleural fluid (procedure) |
Cell tissue autoantibody screening test |
Cell tissue autoantibody screening test (procedure) |
Cell tissue autoantibody screening test |
Cell tissue autoantibody screening test (procedure) |
Cellarman |
Cellarman |
Cellular AND/OR subcellular structure |
Cell |
Cellular ependymoma |
Cellular ependymoma |
Cellulase preparation |
Cellulase |
Cellulase preparation |
Cellulase |
Cellulitis (&/or abscess): [buttock] or [perirectal] |
Cellulitis and abscess of buttock |
Cellulitis and abscess of neck |
Cellulitis and abscess of neck |
Cellulitis and abscess of trunk |
Cellulitis and abscess of trunk |
Cellulitis of axilla |
Cellulitis of axilla |
Cellulitis of eyelid |
Cellulitis of eyelid |
Cellulitis of face |
Cellulitis of face |
Cellulitis of foot |
Cellulitis of foot |
Cellulitis of leg, except foot |
Cellulitis of leg, excluding foot |
Cellulitis of leg, excluding foot |
Cellulitis of leg, excluding foot |
Cellulitis of lip |
Cellulitis of lip |
Cellulitis of neck |
Cellulitis of neck |
Cellulitis of toe |
Cellulitis of toe |
Cellulitis of trunk |
Cellulitis of trunk |
Cellulitis of vocal cords |
Cellulitis of vocal cords |
Cellulose derived viscosity modifier |
Cellulose-derived viscosity modifier (substance) |
Cellulose preparation |
Cellulose |
Cement burn of skin |
Cement burn of skin (disorder) |
Cemental dysplasia |
Dysplasia |
arthroplastie prothétique hybride totale de l'articulation de l'épaule en utilisant du ciment |
Prosthetic hybrid total shoulder replacement |
Cemetery superintendent |
Cemetery superintendent |
Centers for Disease Control and Prevention group EF-4a |
Neisseria animaloris |
Centers for Disease Control and Prevention group EF-4b |
Neisseria zoodegmatis (organism) |
Central abdominal pain |
Central abdominal pain |
Central appetite depressant overdose of undetermined intent |
Central appetite depressant overdose |
Central chest pain |
Central chest pain |
Central corneal ulcer |
Central corneal ulcer |
Central diabetes insipidus |
Vasopressin deficiency |
Central nervous system complications of care |
Central nervous system complications of care |
Central neurocytoma - histology (morphologic abnormality) |
Central neurocytoma |
Central nystagmus &/or vertigo |
Central positional nystagmus |
Central opacity of cornea |
Central opacity of cornea |
Central pterygium |
Central pterygium |
Central retina area |
Structure of posterior pole of eye |
Central serous retinopathy |
Central serous chorioretinopathy (disorder) |
Central sulcus insulae |
Central sulcus of insula |
Central tympanic membrane |
Structure of umbo of tympanic membrane |
Central venous catheter |
Central venous catheter |
Central venous pressure measurement |
Measurement of central venous pressure |
Central venous pressure monitoring |
Central venous pressure monitoring |
recentrage du poignet sur l'ulna |
Centralisation carpus correction for radial club hand |
Centrally inserted central venous catheter |
Central venous catheter |
Centrocecal scotoma |
Centrocecal scotoma |
Centromere antibody level |
Antibody to centromere measurement |
Centromere antibody level |
Antibody to centromere measurement |
Centronuclear myopathy |
Myotubular myopathy |
Cephalexin monohydrate 125mg/5 mL powder for oral suspension |
Cefalexin 25 mg/mL oral suspension |
Cephalexin monohydrate 125mg/5mL suspension |
Cefalexin 25 mg/mL oral suspension |
Cephalexin monohydrate 250mg/5 mL powder for oral suspension |
Product containing precisely cefalexin 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Cephalexin overdose of undetermined intent |
Cephalexin overdose (disorder) |
Cephalexin poisoning of undetermined intent |
Poisoning by cephalexin |
Cephaloglycin - chemical |
Cephaloglycin (substance) |
Cephalophus |
Genus Cephalophus (organism) |